# Allopurinol

## Tonsaric 100mg

| TAH Drug Code      | [OTON](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OTON)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Gout, gouty arthritis, uric acid stones, hyperuricemia caused by cancer or chemotherapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Adults: Antigout agent: Initial dose:100mg QD, increase by 100 mg/day during one-week intervals until the required serum uric acid concentration is reached. maximum:800mg/day. Maintenance dose:100mg-200mg BID-TID, or 300mg QD. The general maintenance dose for people with mild gout is 200 to 300 mg per day. In moderately severe Tophaceaus gout, the general maintenance dose is 400 to 600 mg per day. Neoplastic disease therapy:12 hours to 3 days (preferably 2 to 3 days) before the start of chemotherapy or radiotherapy, 600 mg to 800 mg per day. Antiurolithic(Uric acid caliculi):100-200mg QD. maximum dose: each dose 300mg, 800mg/day Children: Neoplastic disease therapy:<6 years old:50mg TID 6-12 years old: 100mg TID or 300mg QD. After 48 hours of treatment, adjust the dose according to the patient's condition. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | (1) Patients with renal insufficiency or those with conditions that may lead to changes in renal function, such as: congestive heart failure, diabetes, hypertension. (Oxipurinol may accumulate; the risk of severe allergic reactions and other adverse effects may increase; dose reduction may be necessary.) (The risk of renal failure may increase, especially when Allopurinol is used for secondary hyperuricemia due to tumors or urate nephropathy; renal function monitoring may be particularly important in these conditions.) (2) Patients with a history of allergy to Allopurinol.                                                                                                                                                                                                                                               |
| Adverse Effects    | Common: Maculopapular eruption (1% or greater), Rash (1% or greater), Diarrhea (1% or greater), Nausea (1% or greater), Alkaline phosphatase above reference range (1% or greater), ALT/SGPT level raised (1% or greater), Aspartate aminotransferase serum level above reference range (1% or greater), Gout, acute (1% or greater) Serious: Pruritus (< 1%), Stevens-Johnson syndrome (< 1%), Toxic epidermal necrolysis (< 1%), Loss of appetite (< 1%), Weight loss, Agranulocytosis (< 1%), Aplastic anemia (< 1%), Leukopenia (< 1%), Myelosuppression, Thrombocytopenia (< 1%), Granulomatous hepatitis (< 1%), Hepatic necrosis (< 1%), Hepatotoxicity, Drug reaction with eosinophilia and systemic symptoms, Hypersensitivity reaction, Dizziness (< 1%), Somnolence (< 1%), Acute renal failure, Renal failure (< 1%)                  |
| Pregnancy          | No (Limited) Human Data â€“ No Relevant Animal Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/allopurinol-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

